|1.||Offner, Halina: 5 articles (10/2014 - 07/2003)|
|2.||Vandenbark, Arthur A: 5 articles (01/2012 - 07/2003)|
|3.||Burrows, Gregory G: 5 articles (01/2012 - 07/2003)|
|4.||Strominger, Jack L: 3 articles (07/2013 - 06/2002)|
|5.||Selvaraj, P: 3 articles (06/2009 - 04/2001)|
|6.||Narayanan, P R: 3 articles (06/2009 - 04/2001)|
|7.||Fugger, Lars: 3 articles (10/2006 - 06/2002)|
|8.||Oksenberg, J R: 3 articles (03/2003 - 05/2000)|
|9.||Hauser, S L: 3 articles (03/2003 - 05/2000)|
|10.||David, Chella S: 2 articles (11/2015 - 09/2007)|
01/01/2013 - "Structural and dynamical insights on HLA-DR2 complexes that confer susceptibility to multiple sclerosis in Sardinia: a molecular dynamics simulation study."
01/16/2004 - "There is some controversy about the possible relation between HLA-DR2 (DRB1*1501-DRB5*0101-DQA1*0102-DQB1*0602) and the severity of multiple sclerosis (MS), which could be due, at least in part, to methodological differences among the different studies dealing with this subject and/or to a lack of phenotypic homogeneity within the series of patients. "
09/01/2002 - "The HLA-DR2 haplotype (DRB1*1501, DQB1*0602) on chromosome 6p21 has consistently demonstrated both association and linkage with multiple sclerosis (MS) in case-control and family studies, particularly in Caucasians of Northern European descent. "
10/29/1996 - "We have used a PCR-based technology to study the V beta 5 and V beta 17 repertoire of T-cell populations in HLA-DR2 multiple sclerosis (MS) patients. "
01/01/1994 - "Multiple sclerosis (MS) has been associated with HLA-DR2 for more than 20 years, and a large number of studies have addressed the relation between MS and the HLA class II genes, which are our major immune-response genes. "
|2.||Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/01/1993 - "However, the HLA-DR2 antigen, which rarely occurs in IDDM and is considered to confer protection against IDDM, was found in equal distribution (35%) in both patients and controls. "
01/01/1986 - "In the present study, we have analyzed class II DQ alpha, DQ beta, and DR beta restriction fragment length polymorphism (RFLP) in HLA-DR2/Dw-typed healthy, unrelated Israeli individuals, as well as in 11 French HLA-DR2 insulin-dependent diabetes mellitus (IDDM) patients and 11 French DR-matched controls. "
08/01/1994 - "HLA-DR2 is negatively associated with insulin-dependent diabetes mellitus (IDDM). "
01/01/1994 - "A review of published data from the genetic features of this syndrome is performed, establishing the high frequency of the HLA-DR2 antigen in the WS (44.4%) compared with a control group (21.9%; relative risk, 2.8) and to patients with Type 1 insulin-dependent diabetes mellitus (Type 1 diabetes) (6.77%; relative risk, 9.7). "
02/01/1993 - "The frequency distributions of the HLA types DR3, DR4 and DR3/4, which normally confer susceptibility to insulin-dependent diabetes mellitus and of HLA-DR2, which normally confers resistance to insulin-dependent diabetes mellitus, were not different in non-diabetic CF patients, diabetic CF patients and normal subjects. "
10/01/2014 - "We previously demonstrated that RTL1000 was protective against experimental ischemic stroke in HLA-DR2 transgenic (DR2-Tg) mice. "
07/01/2009 - "Treatment with RTL1000 (HLA-DR2 moiety linked to human MOG-35-55 peptide) similarly reduced the stroke lesion size in HLA-DR2 transgenic mice. "
|4.||Pemphigus (Pemphigus Vulgaris)
01/01/1994 - "HLA typing in pemphigus vulgaris patients revealed a significant reduction in HLA-DR2 in New Delhi (p = 0.0008) and Oxford (p = 0.09). "
02/01/1982 - "In contrast, the negative association with HLA-DR2 was observed in Hashimoto's thyroiditis, pemphigus vulgaris and hypertrophic non-obstructive cardiomyopathy."
07/01/2002 - "The results of the present study suggest that an increased BMI in narcolepsy is neither associated with the HLA-DR2 antigen per se nor with medication, but is more likely to be a consequence of disease-associated neuroendocrine abnormalities."
08/01/1987 - "This study confirms that the extremely high association between HLA-DR2 and narcolepsy holds across comparisons of the three races studied to date when both clinical and sleep laboratory data are used. "
01/01/1985 - "In man, extensive family studies suggest either a two-threshold multifactorial model of inheritance or a dominant mode of inheritance and immunologic studies have recently shown a strong association between HLA-DR2 and narcolepsy. "
05/01/2014 - "Following the finding in Japan that almost all patients with narcolepsy carry a specific HLA subtype, HLA-DR2, Hugh Mac Devitt, F. "
06/01/2009 - "Narcolepsy was first shown to be tightly associated with HLA-DR2 (ref. "
|1.||copolymer 1 (glatiramer acetate)
|4.||HLA-DR1 Antigen (HLA DR1 Antigen)
|5.||HLA Antigens (Human Leukocyte Antigens)
|6.||HLA-DR7 Antigen (HLA DR7 Antigen)
|7.||HLA-B8 Antigen (HLA B8 Antigen)
|9.||Antineutrophil Cytoplasmic Antibodies (ANCA)
|10.||HLA-B27 Antigen (HLA B27 Antigen)
|1.||Transplantation (Transplant Recipients)